Cargando…
The Road to Toxin-Targeted Therapeutic Antibodies
Once an infection by a toxin-producing bacterium is well established, therapies such as antibiotics that target bacterial growth may have little impact on the ultimate patient outcome. In such cases, toxin-neutralizing antibodies offer an opportunity to block key virulence factors. New work by A. K....
Autor principal: | Kozel, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161251/ https://www.ncbi.nlm.nih.gov/pubmed/25006234 http://dx.doi.org/10.1128/mBio.01477-14 |
Ejemplares similares
-
Bacterial toxins and the immune system: show me the in vivo targets
por: Galán, Jorge E.
Publicado: (2005) -
Biomarkers That Predict Diabetic Nephropathy: The Long Road From Finding Targets to Clinical Use
por: Klein, Jon
Publicado: (2012) -
The many roads to cross-presentation
por: Groothuis, Tom A.M., et al.
Publicado: (2005) -
The long and winding road to causality
por: Dekkers, Olaf M.
Publicado: (2019) -
Commentary: The road map for collaterals—A scenic route from the Abbey Road to the operating theater?
por: Naimo, Phillip S., et al.
Publicado: (2020)